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Background: Pigs are regarded as the main reservoir for human pathogenic Yersinia enterocolitica, which is
dominated by bioserotype 4/O:3. Other animals, including sheep, have occasionally been reported as carriers of
pathogenic strains of Y. enterocolitica. To our knowledge, this is the first study performed in the Nordic countries in
which the presence of Y. enterocolitica in sheep is investigated.
Methods: Tonsils and faecal samples collected from sheep slaughtered on the island Gotland (Sweden) from
September 2010 through January 2011 were analysed for presence of Y. enterocolitica. In an attempt to maximize
recovery, several cultural strategies were applied. Various non-selective media were used and different temperatures
and durations of the enrichment were applied before subculturing on Cefsulodin Irgasan Novobiocin (CIN) agar.
Presumptive Y. enterocolitica colonies were subjected to urease, API 20E and agglutination test. Yersinia enterocolitica
isolates were biotyped, serotyped, and tested for pathogenicity using a TaqMan PCR directed towards the ail-gene
that is associated with human pathogenic strains of Y. enterocolitica.
Results: The samples collected from 99 sheep yielded 567 presumptive Y. enterocolitica colonies. Eighty urease
positive isolates, from 35 sheep, were identified as Y. enterocolitica by API 20E. Thirty-four of 35 further subtyped Y.
enterocolitica isolates, all from faecal samples, belonged to biotype 1A serotype O:5, O:6. O:13,7 and O:10. One strain
was Yersinia mollaretii serotype O:62. No human pathogenic strains of Y. enterocolitica were found in the
investigated sheep. Other species identified were Y. kristensenii (n = 4), Y. frederiksenii/intermedia (n = 3), Providencia
rettgeri (n = 2), Serratia marcescens (n = 1) and Raoultella ornithinolytica (n = 1).
Conclusions: This study does not support the hypothesis that sheep play an important role in transmission of the
known human pathogenic Y. enterocolitica in the studied geographical region. However, because there are studies
indicating that some strains of Y. enterocolitica biotype 1A may cause disease in humans, the relative importance of
sheep as carriers of human pathogenic strains of Y. enterocolitica remains unclear. Tonsils do not appear to be
favourable sites for Y. enterocolitica biotype 1A in sheep.
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Human pathogenic strains of Yersinia enterocolitica
cause yersiniosis, a food-borne zoonosis. It is a
gastrointestinal pathogen causing symptoms which
vary depending on the age of the host and the bioser-
otype of the infecting strain. The most commonly
reported symptoms are diarrhea, vomiting, abdominal
pain, and fever. There is also a considerable risk of
sequelae; reactive arthritis and erythema nodosum are* Correspondence: karin.soderqvist@slu.se
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distribution, and reproduction in any mediumcommon [1,2] but inflammatory bowel disease and ir-
ritable bowel syndrome are also reported [3]. Yersi-
niosis is the third most commonly reported zoonosis
in Sweden, as well as in the EU. Nearly all cases ap-
pear sporadically and outbreaks are very rare [4]. In
Sweden, yersiniosis is notifiable, and from 2001
through 2010 the annual incidence for the whole
country ranged from 3 to 9 cases per 100 000 inhabi-
tants, but was 5 to 16 on the island Gotland [5]. It is
important to note that approximately 30% of the
cases reported in Sweden are children under five
years of age [6].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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yersiniosis are classified into five biotypes: 1B, 2, 3, 4, and
5. Most of the reported yersiniosis cases in Europe are
caused by Y. enterocolitica biotype 4, serotype O:3 [4].
Biotype 1A strains are widespread in the environment
and are generally considered to be non-pathogenic [2].
There are, however, studies indicating that some of the
1A strains have the ability to cause disease in humans, al-
though they lack the classical virulence markers [7,8].
There are various methods described for isolation of Y.
enterocolitica but no single procedure exists that covers all
common human pathogenic bioserotypes [9]. In sample
matrices of food, environment, and asymptomatic animal
carriers (faeces, tonsils etc.) a large number of various
non-target micro-organisms constitute the background
flora. Unfortunately, the currently available enrichment
and plating media for isolation of pathogenic strains of Y.
enterocolitica are not selective enough to repress the back-
ground flora which increases the risk of false negative
results. PCR can be used to indicate the presence of the
pathogen in a sample before subculture on a solid media
and/or to examine isolated colonies to reveal the presence
of a potentially pathogenic strain. PCR assays that detect
the group of bioserotypes associated with human disease
are available [10].
Strains that belong to bioserotypes associated with
human disease have frequently been isolated from tonsils
and fecal samples of domestic pigs. A number of studies
indicate prevalences of bioserotype 4/O:3 isolated from
tonsils ranging from 38 to 67% [11-13], while correspond-
ing prevalences in samples of pig faeces range from 8 to
13% [12].
At least one out of 4 cases of yersiniosis appears to ori-
ginate from other sources than pigs [14] and there is a
need to investigate alternative putative sources. Different
food-producing animals have been examined as reservoirs
for Y. enterocolitica, but data on the prevalence in sheep is
limited. Human pathogenic strains have been isolated
from sheep samples in a few studies from other countries
[15,16] and a genotype relationship has been established
between strains isolated from humans and sheep in Great
Britain, indicating that sheep may be a potential reservoir
of human pathogenic strains of Y. enterocolitica [17].
In the Island of Gotland (Sweden), there has been a per-
sistent elevated incidence of human yersiniosis and a large
population of sheep suggesting that sheep could be a pos-
sible source. Hence, the objective of this study was to
examine sheep as potential carriers of human pathogenic
strains of Y. enterocolitica.
Methods
Study design and sample collection
About 3000 sheep older than one year (personal com-
munication Örjan Hansson, Gotlands Slagteri AB) wereslaughtered at Gotlands Slagteri AB during the study
period from September 2010 through January 2011. The
establishment is submitted to official control by the Na-
tional Food Agency in Sweden. To detect a prevalence
of human pathogenic Y. enterocolitica of at least 3% with
a 95% Confidence Interval (CI), the number of samples
to be collected (n = 97) was calculated using the software
program Win Episcope 2.0 [18]. The supervisors at the
abattoir were instructed to select the sheep for sampling
at random. From each sheep, the two tonsils were
sampled separately using clean plastic gloves and a ster-
ile scalpel. In addition, approximately 10 g of faeces was
collected from the colon or rectum of the same sheep,
using an aseptic procedure. The slaughter numbers were
recorded to enable tracing of the origin, if necessary. All
samples collected were stored at approximately 8°C and
transported chilled to the laboratory, situated at the Swed-
ish University of Agricultural Sciences (SLU, Uppsala).
Most samples arrived at the laboratory the day after sam-
pling. In most cases analysis started on the day of arrival.
If samples arrived immediately before a weekend they
were stored in a cool incubator at 4°C. When storage was
needed more than three days, samples were stored until
start of analysis in a freezer at −18°C.
In addition, pathogenic strains of Y. enterocolitica iso-
lated from patients contracting yersiniosis during the
study period were collected and stored at the regional
hospital in Gotland (Visby lasarett) before being sent to
SLU for further analysis.
Sample preparation
Culture and identification of Y. enterocolitica
The most efficient methods to detect Y. enterocolitica
from sheep faeces and tonsils are not known. Therefore,
in this study several method variations were tested.
At the laboratory the two tonsils from each sheep were
pooled and cut into even smaller pieces with a sterile
pair of scissors before being divided equally into two fil-
ter bags (StomackerWlab system classic filter bag, www.
Seward.co.uk). The tonsils were very small; about 0.5-3 g
each. Before homogenised, the tissue in one of the bags
was diluted 1:10 with PSB (Phosphate-buffered saline
containing 2% sorbitol and 0.15% bile salts) and in the
second diluted 1:10 with TSBY (Tryptone-soya broth
supplemented with yeast). Samples were then processed
further as outlined in Figure 1. Five to 10 g of a faecal
sample, depending on the amount collected, was initially
diluted 1:10 with Peptone water (PW) before being
homogenised. After being equally divided in two filter
bags, the portions of faecal homogenate were further
diluted (1:10) with PSB and TSBY, respectively, and then
processed as outlined in Figure 1.
The PSB homogenates were pre-incubated for 3 h at
22–25 °C before a 10-μl loop of the enrichment was
Faeces 5-10 gram, 
1:10 PW  Tonsils 1-6 gram       
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Figure 1 Overview of the two culture methods used in this study, both somewhat modified from the original. (i) A method based on the
NMKL method no. 117 (1996), that includes cold enrichment, selective enrichment and subculture on a selective agar plate and (ii) a TaqMan-PCR
based method (Thisted Lambertz, 2008) that includes enrichment overnight in 25°C, PCR analysis and subculture on a selective agar plate. The
step indicated by dotted lines was performed if no characteristic pathogenic Y. enterocolitica colonies were visible on CIN agar day 1. Number
1–6 refer to the different subculturing (CIN) sampling steps as indicated in Table 1. CIN, Cefsulodin Irgasan Novobiocin; PW, Peptone water; PSB,
Phosphate-buffered saline containing 2% sorbitol and 0.15% bile salts; TSBY, Tryptone-soya broth supplemented with yeast; KOH, Potassium
hydroxide solution; MRB, Modified-Rappaport-broth.
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agar plate (Oxoid, CM 653 and SR 109), see pathway (i)
in Figure 1. The PSB broth was incubated, this time at 4 ±
1°C for 21 days (cold enrichment). After eight days, a sub-
portion of 100 μl of the enriched culture was transferred
into 10 ml of MRB (modified-Rappaport-broth). The mix-
ture was homogenised and incubated at 25 ±1°C. After
4 days, 10 and 100 μl, respectively, of the MRB culture
was subcultured on CIN-agar plates. When the cold
enriched culture was 21 days old, 20 μl was subcultured
on CIN-agar plates.
The TSBY homogenates were incubated at 25 ±1°C
for 21 ±3 h, see pathway (ii) in Figure 1. To reduce
the background flora, a 0.5-ml portion of the enrich-
ment was transferred into 4.5 ml 0.5% potassium hy-
droxide solution (KOH) and mixed gently for 20 s
before 10 μl of the mixture was subcultured on a
CIN-agar plate. In parallel, 10 μl of the enrichment
was subcultured directly onto CIN agar, i.e. without
previous KOH treatment. If no characteristic patho-
genic Y. enterocolitica colonies were visible on the
CIN agar plate following KOH treatment after 24 h
incubation of enrichment, a second plating on CIN
agar following KOH treatment was performed after
48 h of enrichment.All CIN-agar plates (1–6 in Figure 1) were incubated
at 30 °C for 21 ±3 h. Colonies with a deep red center
(bull’s eye) surrounded by an outer transparent zone
were considered presumptive Y. enterocolitica. Bull´s eye
colonies were subcultured on segments of a non-
selective agar plate to enable purity and were then trans-
ferred into tubes containing Urea-indole medium and
incubated at 30 ±1°C for 24 ±3 h. Urease-positive cul-
tures (pink colouring of the medium) were biochemically
analysed using API 20E strips (bioMérieux, France) that
were incubated at 30 °C for 24 h. Isolates identified as Y.
enterocolitica were further tested with antisera against Y.
enterocolitica O:3 and O:9 (Reagensia AB, Sweden). A
selection of API 20E-identified Y. enterocolitica isolates
were sent to the Microbiology laboratory, Université
Catholique de Louvain, Brussels (Belgium) for biotyping
according to Wauters et al. [19]. Serotyping was based
on the O-antigens described in the antigenic scheme in-
cluding 76 O-factors characterized among Y. enterocoli-
tica and related species [20].
The collected human strains were biotyped with the
following tests conducted: lipase (tween-esterase), acid
production from salicin, xylose and trehalose, esculin
hydrolysis, Voges-Proskauer and production of pyrazi-
namidase [19,21]. In addition, Congo Red-Brain Heart
Table 1 Outcome of different subculturing steps
Number of strains





1. PSB (i) 0 (3h) 3 0
2. TSBY (ii) 1 7 4
3. TSBY+KOH-treatment (ii) 1 17 8
4. TSBY+KOH-treatment (ii) 2 13 9
5. PSB+MRB (i) 8+4 18 8
6. PSB (i) 21 22 5
Total 80 34
The number of isolates identified as Yersinia enterocolitica (Ye) by API 20E and
biotyped as 1A (BT1A) found at different subculturing (CIN) steps during the
culture procedures applied.
(i), (ii) refers to the different pathways, shown in Figure 1. PSB, Phosphate-
buffered saline containing 2% sorbitol and 0.15% bile salts; TSBY, Tryptone-
soya broth supplemented with yeast; KOH, Potassium hydroxide solution; MRB,
Modified-Rappaport-broth.
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detection of the virulence plasmid [22].
All bioserotyped Y. enterocolitica strains collected in
this study are stored in the NFA (The Swedish National
Food Agency) Culture Collection.
Bacterial reference strains
Yersinia enterocolitica 4/O:3, strain SLV-408 (CCUG
45643) was used as reference and positive control. This
strain was originally isolated from frozen raw dog food,
containing pig meat, and is commercially available.
DNA extraction and TaqMan PCR
In one of the analysis pathways (ii), a PCR analysis was
included. Prior to PCR analysis DNA was extracted from
bacteria cells. The BioROBOT EZ1 (Qiagen) system and
associated kit (EZ1 DNA Tissue Kit (48), Cat. No.
953034) was used for the enriched culture and the Insta
Gene Matrix (Bio-rad, 732–6030) fluid was used regard-
ing lysis of the pure bacterial colonies identified by API
20E as Y. enterocolitica. Both extraction methods were
performed according to the manufacturer’s instructions.
A test portion of 5 μl of the DNA extraction alterna-
tively lysed bacteria was used for PCR analysis. A Taq-
Man probe-based PCR method targeting the ail-gene
[10] was used. In the PCR analysis, the reference strain
SLV-408 was used as positive amplification control and
sterile distilled water as negative control.
A pre-study was carried out to check the possible in-
fluence of PCR-inhibiting substances present in the
matrices tonsil tissue and faeces, and to estimate an ap-
proximate detection level. The two sample matrices were
inoculated with 10-μl portions of appropriate concentra-
tions of an overnight (30 °C) BHI-broth culture of the
reference strain, SLV-408, containing approximately
109 cfu/ml, serial diluted ten-fold in PW to achieve
levels of Y. enterocolitica ranging from 100-104 cfu/ml.
Absence of pathogenic Y. enterocolitica in the matrices
was confirmed by including a negative control sample in
each test. The 1:10 diluted TSBY-inoculated samples
were homogenised and incubated overnight at 25 ±1°C.
DNA was extracted and PCR analysis performed. For
each matrix, this test was run in duplicate. To estimate
the number of Y. enterocolitica bacteria contained in the
inoculums, 100-μl volumes (x3) from the dilutions 10-6
to 10-8 were subcultured on a non-selective agar
medium and incubated overnight at 30 ±1°C, after which
the colonies were counted.
Results
Culture and identification of Y. enterocolitica
Although tonsil and faecal samples were collected from
105 sheep after slaughter, only samples from 99 sheep
were used. A group of samples from six sheep wasdelayed more than 48 h and therefore excluded from the
study. In all, 567 colonies grown on CIN agar were iden-
tified as presumptive Y. enterocolitica and of those, 95
(17%) were urease positive. API 20E identified the ma-
jority (80/95) of the urease isolates as belonging to the
species Y. enterocolitica, however, in varying degree
according to the API species definition: four with ‘Very
good identification’, 66 with ‘Good identification’; five
with ‘Very good identification to the genus’ and five with
‘Doubtful profile’ although Y. enterocolitica was men-
tioned as one significant taxa.
The isolates identified as Y. enterocolitica (n = 80) all
originated from faecal samples collected from 35 of the
sheep (35%). One of these sheep also carried API 20E-
identified Y. enterocolitica in the tonsils. Furthermore,
four isolates were identified as Y. kristensenii, three as Y.
frederiksenii/intermedia, two as Providencia rettgeri, one
as Serratia marcescens and one as Raoultella ornithino-
lytica. None of the isolates became positive in agglutin-
ation tests with antisera O:3 or O:9. The first 35 out of
the 80 API 20E-identified Y. enterocolitica isolates were
bioserotyped. Out of the 35 isolates, 27 belonged to 1A/
O:5, four to 1A/O:6, two to 1A/O:13,7 and one to 1A/
O:10. One isolate was identified as Yersinia mollaretii,
serotype O:62.
The number of Y. enterocolitica 1A strains recovered
in all 6 subculturing (CIN) steps is given in Table 1. Cul-
turing after enrichment in TSBY for one or two days
combined with KOH treatment (no 3 and 4) were the
most effective methods to isolate Y. enterocolitica 1A.
Selective enrichment in MRB (no 5) was also effective.
No Y. enterocolitica 1A was isolated after direct culture
on CIN agar plates from pre-incubated PSB.
The human Y. enterocolitica isolates (n = 2) were
trehalose- and Voges-Proskauer positive but lipase-,
salicin-, xylose-, esculin- and pyrazinamidase negative;
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were serotyped as O:3, according to the slide agglutin-
ation test. Both strains carried the virulence plasmid
(CR-BHO).
TaqMan PCR
The results of the prestudy showed that faecal matrix
caused considerable PCR inhibition compared to tonsils.
When using the EZ1 BioROBOT to extract DNA, ac-
ceptable levels of PCR detection for the two matrices
were obtained after an initial dilution of the faecal sam-
ples 1:10. An extraction-elusion volume of 200 μl for the
faecal samples and 50 μl for the tonsil samples were ap-
plied. Using this DNA extraction setup it was possible to
detect approximately 102 to 103 cfu Y. enterocolitica per
gram of faecal or tonsil sample.
The ail-gene was not found in any of the sample
enrichments, and was not detected when testing the
urease-positive Y. enterocolitica isolates (n = 95). How-
ever, in the two human strains collected in Gotland, the
ail-gene was detected.
Discussion
This study shows the presence of Y. enterocolitica in
tonsil and faecal samples of sheep. The sheep were bred
and slaughtered on Gotland, a Swedish island that also
has swine and cattle production. In this study no human
pathogenic biotype was isolated and no ail-gene was
detected. However, a whole set of Y. enterocolitica bio-
type 1A was found, where 34 out of 35 bioserotyped iso-
lates belonged to this biotype. The absence of human
pathogenic Y. enterocolitica strains in this study is at
variance with findings in studies outside Sweden. Bioser-
otype 4/O:3 has been isolated from the rectal content in
12% of lambs (33/281) in a survey from New Zealand
[15] and bioserotype 3/O:5,27 has been isolated from
faeces in 3% of sheep (30/973) in a British study [23]. A
high seroprevalence (56%) of yersinia antibodies was
found in sheep in Northern Germany [24]. However, an-
other German study detected the ail-gene only in 5% (3/
64) of the sheep tonsil samples and in none of 200 ana-
lysed faecal samples [12]. A study in Nigeria detected
the ail-gene in 1% (2/200) of faeces samples in investi-
gated sheep [25].
The incidence of yersiniosis was low during the inves-
tigation period (mainly 2010), both in Gotland and in
Sweden as a whole. Still, the incidence in Gotland was
higher than the Swedish average [5]. There were two
reported cases of human yersiniosis in the study area
during the study period, and bioserotype 4/O:3 was iso-
lated from both of them. During 2011, Y. enterocolitica
2/O:9, carrying the ail-gene, was isolated from the faecal
samples of 4 sheep from Skåne in southern Sweden (per-
sonal communication, Elisabeth Bagge, National VeterinaryInstitute). During the same year there were 11 reported
human cases of yersiniosis caused by Y. enterocolitica
2/O:9 in Sweden (personal communication Margareta
Löfdahl, SMI).
Strains of biotype 1A are ubiquitous in the environ-
ment and generally considered to be non-pathogenic [2].
The latter is, however, subject to discussion [8]. Some
studies suggest that biotype 1A lacks clinical signifi-
cance, because biotype 1A has been isolated more fre-
quently in healthy subjects than in patients with
intestinal disease [7]. Other studies suggest the opposite;
that Y. enterocolitica biotype 1A is associated with clin-
ical disease [8,26,27]. In recent studies from Switzerland
and Finland, the prevalence of isolated Y. enterocolitica
biotype 1A from yersiniosis-patients was high, 40 and
65% respectively. The biotype 1A patients were older
and had another spectrum of symptoms than patients
from whom traditionally pathogenic biotypes of Y. enter-
ocolitica were isolated [8,28]. A few biotype 1A strains
were also found amongst the reported cases from 2008
to 2011 in Sweden (Margareta Löfdahl, SMI, personal
communication). Cold enrichment is not used for clin-
ical samples in Sweden which could be one reason for
the less frequent finding of biotype 1A strains in Sweden
compared to in Finland where they often use this
method [28].
One of the classic virulence factors, the ail-gene, has
been detected in low frequencies in strains of biotype
1A [29,30]. Kraushaar et al. [31] found that the ail re-
gion of a biotype 1A strain differed from the corre-
sponding region of pathogenic strains. Furthermore,
there are indications that biotype 1A strains of clinical
origin from human cases have characteristics that differ
significantly from those that are not from human cases
[7]. Batzilla et al. [32] found genes in biotype 1A encod-
ing known and suspected virulence-associated determi-
nants, indicating their opportunity to establish infection
in immunosuppressed patients. The role of Y. enterocoli-
tica biotype 1A in causing disease in humans is debated
and a priority for research is to investigate virulence
mechanisms other than those currently known.
It was not obvious which bioserotypes of Y. enterocoli-
tica the samples in this study would harbour. Therefore
isolation methods were chosen that allowed a broad
spectrum of bioserotypes to grow. Mainly non-selective
culture media were used in this study (TSBY and PSB).
In parallel, a selective enrichment medium was also used
(MRB). The latter is known to favour growth of the
human pathogenic serotypes O:3 and O:9 and inhibits
most of the background flora [33]. However, in the
present study the use of MRB did not seem to inhibit
other yersiniae. In fact, MRB enrichment was effective in
culturing biotype 1A (see Table 1). CIN agar is the best
available choice of solid medium for isolation of different
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eral other bacteria also grow on the CIN medium, and
the selection of presumptive Y. enterocolitica is difficult.
In the present study there was a reduction of the pre-
sumptive colonies from 567 to 95 after urease testing,
indicating the difficulties in selecting colonies with typ-
ical morphology. It appears that when studying new po-
tential reservoirs for Y. enterocolitica it is important to
use methods that do not discriminate certain serotypes
and bias the results. In the British study, cold enrich-
ment in PSB broth was the only method used and KOH-
treatment was not used to reduce the background flora.
Biotype 1A was the most common strain isolated, 6.6%
of the sheep carried this biotype [23]. Our result indi-
cates a higher prevalence of biotype 1A than observed in
the British study.
In the present study, traditional culturing methods
were combined with real-time PCR detecting the ail-
gene. A BioROBOT EZ1 was used to extract DNA prior
to PCR, which is more effective than extraction with the
DNeasy Blood and Tissue kit (Qiagen GmbH, Hilden
Germany). The BioROBOT EZ1 only requires 200 μl of
the sample, while the DNeasy Blood and Tissue kit
requires 1 ml to yield the same PCR result, i.e. the same
Ct value when testing low value of Y. enterocolitica bac-
teria (approx.102 cfu/ml). The selective and non-
selective isolation methods used, combined with BioRo-
bot extraction and TaqMan PCR, optimizes the chance
to find Y. enterocolitica.
API 20E is not optimally developed for identification
of the non-pathogenic strains of Y. enterocolitica. A cor-
rect identification of the non-pathogenic strains there-
fore requires additional tests [16], as demonstrated by
the results obtained in this study where some of the iso-
lates that had doubtful profiles were later identified as
Y. enterocolitica biotype 1A. One isolate that was classi-
fied as Y. enterocolitica in API 20E with ‘very good iden-
tification’ was in fact Yersinia mollaretii which is
phenotypically closely related to Y. enterocolitica. Yersi-
nia mollaretii was earlier described as Y. enterocolitica
biotype 3A [34].
Conclusions
Sheep from Gotland do not appear to be important in
the transmission of traditionally pathogenic strains of Y.
enterocolitica to humans. There is a high frequency of Y.
enterocolitica biotype 1A in the faecal samples from the
investigated sheep but not in the tonsils. It appears that
when studying new potential reservoirs for Y. enterocoli-
tica it is important to use methods that do not discrim-
inate certain serotypes and therefore bias the results.
The zoonotic potential of biotype 1A has received more
attention recently and identification of pathogenic sub-
groups is a future challenge for research.Competing interests
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